ZINZINO AB (PUBL): Share subscription due to warrants
In the option programme Zinzino's general meeting decided on 2020-05-15, 751,617 B shares have been subscribed. The price per share was SEK 45 and in total Zinzino's equity was raised by SEK 33,822,765.
In the option programme Zinzino's general meeting resolved on 31 May 2022, 150,214 B shares have been subscribed (series 2022/2027:1). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 8,411,984.
In the option programme Zinzino's general meeting resolved on 31 May 2022, 35,000 shares have been subscribed (series 2022/2027:2). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 1,960,000.
The total number of B shares increased by 936,831 to 30,650,635. The total number of shares after the increase was 35,764,027. The dilution amounted to 2.62 per cent. Zinzino's share capital increased to SEK 3,576,402.70.
For more information please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Images for free publication:
Certified Adviser:
Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, and Australia.